The multidimensional role of Platelet-Related factors in the occurrence and development of colorectal cancer.

Platelets, traditionally recognized as core components of the coagulation system, have emerged as critical regulators in the multistep progression of colorectal cancer (CRC) beyond their hemostatic functions. Accumulating evidence demonstrates that platelets orchestrate a multidimensional network to promote CRC initiation, proliferation, invasion, metastasis, and immune escape through direct interactions with tumor cells, modulation of the tumor microenvironment, and regulation of angiogenic processes. Two key platelet surface molecules, P-selectin (CD62P) and C-type lectin-like receptor-2 (CLEC- 2), serve as central hubs in these pro-tumorigenic cascades: CD62P mediates platelet-tumor cell aggregation, extravasation, and immunosuppressive macrophage polarization, while CLEC-2 interacts with its ligand podoplanin (PDPN) to drive platelet activation, tumor cell epithelial-mesenchymal transition, and cancer-associated thrombosis. In-depth research into their mechanisms of action is of great significance for the development of targeted therapeutic drugs for colorectal cancer.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-18
DOI
https://doi.org/10.14670/hh-25-177
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The multidimensional role of Platelet-Related factors in the occurrence and development of colorectal cancer.

Yuyu Chen, Haobo Zhang
3 links
PubMed
Platelet Disorders and Treatments
article

The multidimensional role of Platelet-Related factors in the occurrence and development of colorectal cancer.

Yuyu Chen, Haobo Zhang
article en

Abstract

Platelets, traditionally recognized as core components of the coagulation system, have emerged as critical regulators in the multistep progression of colorectal cancer (CRC) beyond their hemostatic functions. Accumulating evidence demonstrates that platelets orchestrate a multidimensional network to promote CRC initiation, proliferation, invasion, metastasis, and immune escape through direct interactions with tumor cells, modulation of the tumor microenvironment, and regulation of angiogenic processes. Two key platelet surface molecules, P-selectin (CD62P) and C-type lectin-like receptor-2 (CLEC- 2), serve as central hubs in these pro-tumorigenic cascades: CD62P mediates platelet-tumor cell aggregation, extravasation, and immunosuppressive macrophage polarization, while CLEC-2 interacts with its ligand podoplanin (PDPN) to drive platelet activation, tumor cell epithelial-mesenchymal transition, and cancer-associated thrombosis. In-depth research into their mechanisms of action is of great significance for the development of targeted therapeutic drugs for colorectal cancer.

PubMed
Central South University (CN), Hunan Cancer Hospital (CN), Xiangya Hospital Central South University (CN)
Good health and well-being
Platelet Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon